Inactive Instrument

Highlights Viveve Medical Inc Nasdaq

Equities

CA92852W2040

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2023	InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	CI
2023	Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	25/23/25	CI
Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday	17/23/17	MT
Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study; Unveils Cut in Workforce; Expects Delisting From Nasdaq	17/23/17	MT
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence	17/23/17	CI
Viveve Medical, Inc. Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence	15/22/15	CI
Viveve Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q3 Revenue $1.7M	11/22/11	MT
Viveve Medical, Inc. Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence	04/22/04	CI
Viveve Medical, Inc. Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Pivotal Pursuit Trial Readout	27/22/27	CI
Viveve Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/22/12	CI
Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q2 Revenue $1.8M, vs. Street Est of $1.76M	12/22/12	MT
Viveve Medical Says Taiwan Intellectual Property Office Awarded Patent for Viveve's Dual-Energy Technology	12/22/12	MT
Earnings Flash (VIVE) VIVEVE MEDICAL Reports Q1 Revenue $1.6M, vs. Street Est of $1.61M	13/22/13	MT
Viveve Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13	CI
Viveve Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	18/22/18	CI
Viveve Medical Completes Enrollment in Bladder Control Trial	14/21/14	MT
Viveve Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/21/12	CI
Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q3 Revenue $1.6M, vs. Street Est of $1.69M	12/21/12	MT
Viveve Medical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	13/21/13	CI
Viveve Medical : Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q2 Revenue $1.65B	13/21/13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Viveve Medical Inc Nasdaq

Equities

CA92852W2040

Highlights

Filters